Solvy Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 790.33%
(FY 2023)
- Profit -1091.28%
(FY 2023)
- Ebitda -6463.59%
(FY 2023)
- Net Worth -1462.38%
(FY 2023)
- Total Assets 78.99%
(FY 2023)
About Solvy Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Balaram Pandey, Gopal Pandey, Savita Pandey, and One other member serve as directors at the Company.
- CIN/LLPIN
U85310GJ2018PTC103010
- Company No.
103010
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2018
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Solvy Remedies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balaram Pandey  | Director | 26-Jun-2018 | Current |
| Gopal Pandey | Director | 26-Jun-2018 | Current |
| Savita Pandey | Director | 26-Jun-2018 | Current |
| Gaurav Mishra | Director | 25-Jan-2021 | Current |
Financial Performance of Solvy Remedies.
Solvy Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 790.33% increase. The company also saw a substantial fall in profitability, with a 1091.28% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1462.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solvy Remedies?
In 2023, Solvy Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wellduphargrand Healthcare Private LimitedActive 6 years 2 monthsBalaram Pandey, Gopal Pandey and 1 more are mutual person
- Primeshreya Remedies Private LimitedActive 6 years 2 months
Balaram Pandey, Gopal Pandey and 1 more are mutual person
- Shrishivay Sankatmochan Pharma Private LimitedActive 6 years 5 months
Balaram Pandey, Gopal Pandey and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Solvy Remedies?
Unlock and access historical data on people associated with Solvy Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solvy Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solvy Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
